Our company is a reputed provider of optimum quality Canagliflozin CAS 842133-18-0. Canagliflozin is a novel, potent, and highly selective sodium glucose co-transporter (SGLT) 2 inhibitor. Experiment shows that Canagliflozin can increase urine glucose excretion by decreasing the filtered glucose re-absorption and by reducing the renal glucose threshold. Canagliflozin 842133-18-0 is widely used to treatment of type 2 diabetes. Customers can avail the Canagliflozin CAS NO 842133-18-0 as per their needs.
Thera. Category: Anti-Diabetes
Cas No.: 842133-18-0
Synonym: (1S)-1,5-Anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-D-glucitol;Canagliflozin;JNJ 24831754ZAE;JNJ 28431754;JNJ 28431754AAA;TA 7284;Canaglifozion;D-Glucitol, 1,5-anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]Methyl]-4-Methylphenyl]-, (1S)-
Molecular Formula: C24H25FO5S
Molecular Weight: 444.5157032
Assay: ≥99.%
Packing: Export worthy packing
lMaterial Safety Data Sheet: Available on request
Usage: Canagliflozin is a novel, potent, and highly selective sodium glucose co-transporter (SGLT) 2 inhibitor which is widely used in treatment of type 2 diabetes and obesity.